KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Inventory (2020 - 2026)

Organon has reported Inventory over the past 7 years, most recently at $1.4 billion for Q1 2026.

  • For Q1 2026, Inventory rose 0.81% year-over-year to $1.4 billion; the TTM value through Mar 2026 reached $1.4 billion, up 0.81%, while the annual FY2025 figure was $1.4 billion, 6.43% up from the prior year.
  • Inventory for Q1 2026 was $1.4 billion at Organon, down from $1.4 billion in the prior quarter.
  • Over five years, Inventory peaked at $1.5 billion in Q3 2025 and troughed at $879.0 million in Q3 2022.
  • A 5-year average of $1.2 billion and a median of $1.3 billion in 2024 define the central range for Inventory.
  • Biggest five-year swings in Inventory: dropped 4.25% in 2022 and later soared 34.93% in 2023.
  • Year by year, Inventory stood at $1.0 billion in 2022, then surged by 31.11% to $1.3 billion in 2023, then increased by 0.46% to $1.3 billion in 2024, then grew by 6.43% to $1.4 billion in 2025, then fell by 2.35% to $1.4 billion in 2026.
  • Business Quant data shows Inventory for OGN at $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.5 billion in Q3 2025.